Authors


Trevor Dyson-Hudson, MD

Latest:

Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord Injury

The director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.


Aaron Boster, MD

Latest:

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.



Amit Bar-Or, MD, FRCPC

Latest:

BTKi Treatment Paradigm

Neurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.


Paul Newhouse, MD

Latest:

Paul Newhouse, MD: Muscarinic Agonists in Alzheimer Treatment

The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.



Kenneth Bender, PharmD, MA

Latest:

The “Grave Threat” Posed by the Shortage of Neurologists

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.


Peii Chen, PhD

Latest:

Peii Chen, PhD: Addressing Spatial Neglect After Stroke

The senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.


NeurologyLive® Staff

Latest:

This Week on NeurologyLive® — March 31, 2025

Here's some of what is coming soon to NeurologyLive® this week.


John Corboy, MD

Latest:

John Corboy, MD: The DISCO-MS Trial

The professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.



Ashley Aaroe, MD

Latest:

Neurology on the Hill: My Role as an Advocate for Neurology

Neuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.



Steve Chung, MD

Latest:

Steve Chung, MD: Cannabidiol in Tuberous Sclerosis Complex

The neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.



Karen J. Nolan, PhD

Latest:

Karen J. Nolan, PhD: Functional Implementation of Robotics in Neurorehabilitation

The senior research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation spoke to the research being done into the functional implementation of exoskeletons in neurorehabilitation.


Shaun Hussain, MD, MS

Latest:

Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile Spasms

The director of Infantile Spasms Program at UCLA Mattel Children’s Hospital discussed why learning more about patients with infantile spasms may lead to further breakthroughs on the origins of autism spectrum disorder.


Brian Grosberg, MD

Latest:

Treatment Challenges for Migraine During Pregnancy: Brian Grosberg, MD, FAHS

The medical director of the Hartford healthcare Headache Center in Connecticut discussed the significance of findings from a study assessing migraine during pregnancy. [WATCH TIME: 4 minutes]


Jerome Engel, Jr., MD, PhD

Latest:

Jerome Engel, Jr., MD, PhD on Referring Patients to Epilepsy Centers

The Director of the UCLA Seizure Disorder Center explained the importance of referring patients with seizures to epilepsy centers.


Shai Efrati, MD

Latest:

Shai Efrati, MD: Assessing Hyperbaric Oxygen Therapy for Neurodegeneration

The director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center offers takeaways on hyperbaric oxygen therapy.


Erica Slaughter, MS

Latest:

Managing Psychosis in Parkinson Disease: Challenges and Opportunities

Although the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.


Augusto Miravalle, MD

Latest:

Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?

Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.


Thomas Leist, MD

Latest:

Thomas Leist, MD: Resetting the Immune System With Cladribine

The director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University discussed the concept of lymphocyte depletion to reset the immune system.


Nancy R. Foldvary-Schaefer, DO, FAAN

Latest:

Postictal Generalized EEG Suppression as a Biomarker for SUDEP: Nancy R. Foldvary-Schaefer, DO, FAAN

The director of the Sleep Disorders Center and staff in the Epilepsy Center at Cleveland Clinic discussed how additional sensors in seizure monitoring for patients with epilepsy may help better manage the risk of SUDEP. [WATCH TIME: 3 minutes]



Anton P. Porsteinsson, MD

Latest:

Overviewing Design and Topline Data From Phase 3 APOLLOE4 Study of Valiltramiprosate in Alzheimer Disease: Anton Porsteinsson, MD

The director of the Alzheimer’s Disease Care, Research, and Education Program at the University of Rochester provided clinical insight on a pivotal trial testing a novel therapeutic in patients with Alzheimer disease who are carriers of APOE4/4. [WATCH TIME: 7 minutes]


Fred Lublin, MD

Latest:

NeuroVoices: Fred Lublin, MD, on Shifting From Phenotypes to Spectrum-Based Perspectives to Advance Multiple Sclerosis Care

The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai talked about how modern advances research have helped transition the understanding of multiple sclerosis from fixed phenotypes to a dynamic spectrum.


M. Scott Perry, MD

Latest:

Meet & Greet: Pediatric Epilepsy Research Consortium

M. Scott Perry, MD, an expert in epileptic disorders and board president of PERC, provided insights on the group's mission and goals, its structure and membership, and its 60+ ongoing research projects.


Richard Rudick, MD

Latest:

Richard Rudick, MD: The CogEval App in Clinical Practice

The goal of the free application is to make cognitive assessments routine in multiple sclerosis treatment.


Isabelle Lambert

Latest:

Isabelle Lambert, MD: Spike, Spindle Frequency in Hippocampus During NREM Affect Long-Term Memory

Impairment of physiological spindle activity in the hippocampus during NREM sleep by interictal epileptic activities may have negative consequences on long-term memory consolidation.

© 2025 MJH Life Sciences

All rights reserved.